Home Cart Sign in  
Chemical Structure| 5560-59-8 Chemical Structure| 5560-59-8

Structure of Alverine citrate
CAS No.: 5560-59-8

Chemical Structure| 5560-59-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alverine Citrate is a 5-HT1A receptor antagonist with IC50 value of 101 nM.

Synonyms: NSC 35459; Alverine (citrate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alverine citrate

CAS No. :5560-59-8
Formula : C26H35NO7
M.W : 473.56
SMILES Code : CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.O=C(CC(C(O)=O)(O)CC(O)=O)O
Synonyms :
NSC 35459; Alverine (citrate)
MDL No. :MFCD00035086
InChI Key :RYHCACJBKCOBTJ-UHFFFAOYSA-N
Pubchem ID :21718

Safety of Alverine citrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P280

Related Pathways of Alverine citrate

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
T6PNE cells 20µM 2 days activated the endogenous human insulin promoter ACS Chem Biol. 2013 Aug 16;8(8):1730-6
T6PNE cells 20µM 3 days activated the insulin promoter-GFP transgene ACS Chem Biol. 2013 Aug 16;8(8):1730-6
MDA-MB-231 cells 30 μg/ml 48 h enhance the cytotoxic effects of MG132 on breast cancer cells Int J Mol Med. 2009 Feb;23(2):205-9
HepG2 cells 20µM or 40µM 16 h altered proteolytic sensitivity in HNF4α protein ACS Chem Biol. 2013 Aug 16;8(8):1730-6
HEK293T cells 0 to 200 µM 24 h To assess the effect of Alverine on NF-κB transcriptional activity using luciferase reporter gene assays, results showed that Alverine dose-dependently inhibited NF-κB luciferase activity in HEK293T cells overexpressing MyD88 or TRIF. Biomolecules. 2020 Apr 15;10(4):611
RAW264.7 cells 0 to 200 µM 6 to 24 h To evaluate the inhibitory effect of Alverine on NO production in LPS- or poly(I:C)-activated RAW264.7 cells, results showed that Alverine dose- and time-dependently inhibited NO production, with maximum inhibition rates of 61% (LPS) and 55% (poly(I:C)). Biomolecules. 2020 Apr 15;10(4):611
guinea-pig detrusor smooth muscle cells 10 μM Alverine increased the frequency and amplitude of spontaneous action potentials, decreased the rate of decay of action potentials, suggesting inhibition of L-type Ca channel inactivation. Br J Pharmacol. 2007 Dec;152(8):1228-38

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice HCl/EtOH-induced acute gastritis model Oral 100 and 200 mg/kg Twice per day for 2 days To evaluate the anti-inflammatory effects of Alverine in an HCl/EtOH-induced gastritis mouse model, results showed that Alverine dose-dependently ameliorated gastric ulcerative lesions and reduced iNOS and TNF-α mRNA expression levels in stomach tissues. Biomolecules. 2020 Apr 15;10(4):611

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.56mL

2.11mL

1.06mL

21.12mL

4.22mL

2.11mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories